Kalbe Farma Sets Up R&D Base in Singapore to Focus on Drug Development of Biopharmaceuticals
To advance its vision to become a leading biopharmaceutical company, Innogene also collaborates with other local and international companies, researchers and institutions to acquire, develop and patent innovative pharmaceuticals and diagnostic products for the global market. They include Fraunhofer-Gessellschaft, Europe's largest applied science organisation to develop affordable diagnostic kits for Hepatitis C, Canada's YM BioSciences Inc to develop nimotuzumab also known as hR3 for treating brain tumour and Recombio, a Swiss company to develop a cancer vaccine, IE10, for the treatment of non small cell lung carcinoma and breast cancer. Innogene is also working with Singapore's Lynk Biotechnologies to develop and license out innovative products for application in different therapeutic classes.
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.